Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Blagden

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
British Journal of Cancer|September 11, 2003
Performance status score: do patients and their oncologists agree?S P Blagden, S C Charman, L D Sharples, et al.
British Journal of Cancer|February 22, 2002
The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumoursS P Blagden, M A Foskett, R A Fisher, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 16, 2025
Clinical Impact of Next-Generation Sequencing-Guided Targeted Therapies in Advanced Cancer: A Systematic Review and Meta-AnalysisF Kazmi, R Katyal, T F D Liu, et al.
British Journal of Cancer|November 15, 2007
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumoursG Attard, J Kitzen, S P Blagden, et al.
Oncogene|December 23, 2014
LARP1 post-transcriptionally regulates mTOR and contributes to cancer progressionM Mura, T G Hopkins, T Michael, et al.
Gynecologic Oncology|June 1, 2021
OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancerE Frangou, G Bertelli, S Love, et al.
British Journal of Cancer|March 6, 2008
A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumoursS P Blagden, L R Molife, A Seebaran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumorsJ C Soria, H K Gan, S P Blagden, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
British Journal of Cancer|September 11, 2003
Performance status score: do patients and their oncologists agree?S P Blagden, S C Charman, L D Sharples, et al.
British Journal of Cancer|February 22, 2002
The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumoursS P Blagden, M A Foskett, R A Fisher, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 16, 2025
Clinical Impact of Next-Generation Sequencing-Guided Targeted Therapies in Advanced Cancer: A Systematic Review and Meta-AnalysisF Kazmi, R Katyal, T F D Liu, et al.
British Journal of Cancer|November 15, 2007
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumoursG Attard, J Kitzen, S P Blagden, et al.
Oncogene|December 23, 2014
LARP1 post-transcriptionally regulates mTOR and contributes to cancer progressionM Mura, T G Hopkins, T Michael, et al.
Gynecologic Oncology|June 1, 2021
OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancerE Frangou, G Bertelli, S Love, et al.
British Journal of Cancer|March 6, 2008
A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumoursS P Blagden, L R Molife, A Seebaran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumorsJ C Soria, H K Gan, S P Blagden, et al.
Pageof 1